Randhawa Simrat 4
4 · Dianthus Therapeutics, Inc. /DE/ · Filed Sep 25, 2025
Insider Transaction Report
Form 4
Randhawa Simrat
EVP, Head of R&D
Transactions
- Award
Stock Option (Right to Buy)
2025-09-23+60,000→ 60,000 totalExercise: $37.87Exp: 2035-09-23→ Common Stock (60,000 underlying)
Footnotes (1)
- [F1]The shares of common stock underlying this stock option award will vest in equal monthly installments over the four years after September 23, 2025, subject to the Reporting Person's continued service to the Issuer on each such vesting date.